Sign up
Quantellect · Congress · Trade Detail
NASDAQ: ACADACADIA Pharmaceuticals Inc
RepublicanHouse

Chris Jacobs sold ACADIA Pharmaceuticals Inc (NASDAQ: ACAD)

Chris Jacobs (R-NY), a U.S. Representative, has disclosed 2 trades in ACADIA Pharmaceuticals Inc (ACAD) since 2020, all sales, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Chris Jacobs sold $1,001 - $15,000 of ACADIA Pharmaceuticals Inc (NASDAQ: ACAD) on September 8, 2020. Since that trade, ACAD is down -31.05% against the S&P 500 up +137.11%, an outperformance of -168.16%.

Across these filings, Chris Jacobs has been a net seller of ACAD. The most recent disclosed ACAD transaction shown was dated June 16, 2022. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ACAD trades
2
Disclosed Vol
$16K
Buys
0
0%
Sells
2
100%
Buy / Sell
0.00
ratio
First → Last
2020–2022

Chris Jacobs's ACAD trades vs the price

ACAD is down -31.05% since Chris Jacobs sold on September 8, 2020, versus +137.11% for the S&P 500.

Performance since this trade

Price change since trade
-31.05%
S&P 500 change since trade
+137.11%
Outperformance vs S&P 500
-168.16%

All Chris Jacobs ACAD trades

TradedTypeSizeReturnEst. profit
June 16, 2022SELL$19.51+35.01%
September 8, 2020SELL$38.20-31.05%

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Chris Jacobs & ACAD trading FAQ

Is it legal for Chris Jacobs to trade ACADIA Pharmaceuticals Inc (ACAD) stock?

Yes. Members of Congress are allowed to trade individual stocks, including ACADIA Pharmaceuticals Inc (ACAD), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Chris Jacobs sell ACAD?

Chris Jacobs disclosed a sale of $1,001 - $15,000 of ACADIA Pharmaceuticals Inc (ACAD) on September 8, 2020, according to public STOCK Act filings.

How has ACAD performed since Chris Jacobs's trade?

Since Chris Jacobs sold ACAD on September 8, 2020, the stock is down -31.05%, versus +137.11% for the S&P 500 over the same period, an outperformance of -168.16%.

How many times has Chris Jacobs traded ACAD?

Chris Jacobs has disclosed 2 ACAD trades since 2020. Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ACAD trades?

Quantellect tracks every disclosed congressional trade in ACADIA Pharmaceuticals Inc (ACAD) on the ACADIA Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.

Chris Jacobs's ACAD tradesAll congressional filings for ACADIA Pharmaceuticals IncChris Jacobs's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.